Lorna Rothery discussed the challenges associated with the safe transfusion and supply of blood with Dr Evan M. Bloch, focusing on where future efforts to reduce transfusion-transmitted infections should be directed.
Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.
Here, Open Access Government explore how the National Eye Institute in the U.S is supporting vision research that encompasses visual impairment diseases of people of all ages.
Makoto Suematsu, President of the Japan Agency for Medical Research and Development (AMED) details the challenges around global data sharing for orphan diseases.
Professor Ian N Bruce MD FRCP, Professor of Rheumatology at the University of Manchester shares his expertise here on Systemic Lupus Erythematosus (SLE), a chronic multisystem autoimmune condition.
With diabetes on the increase in the UK, Dr Louise Gow, Specialist Lead for Eye Health at The Royal National Institute of Blind People (RNIB) explains more about the condition and how it can affect the eyes.
Dr Stefan H. Bossmann and Dr Christopher T. Culbertson, Professors of Chemistry at Kansas State University, explain why microfluidic devices are in their view, the future.
Parents of primary school starters urged to check immunisation records after Public Health England (PHE) warns that 1 in 7 five-year-olds may not be fully immunised against MMR.
Dr Gerry Morrow explains what you need to know about an aspect of ophthalmology called uveitis, defined as inflammation of the uveal tract, which comprises the iris, ciliary body and choroid.
Dineke Zeegers Paget, Executive Director of the European Public Health Association (EUPHA) provides a fascinating glimpse of the new challenges for public health in the 21st century.
Alice Reid and Richard Smith, University of Cambridge explore the links between tuberculosis (TB) mortality, occupations, rural and urban residence and migration in late Victorian Scotland.
The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could help England become the first country in the world to eliminate the deadly virus and lead a global elimination.
A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
Diseases could be detected even before people experience symptoms, thanks to a pioneering new health-data programme as part of the government’s modern Industrial Strategy.
